COCRYSTAL PHARMA INC (COCP)
US19188J4094 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -17.98M | -38.84M | -14.19M | -9.65M | -48.17M | |||
| Depreciation Amortization | 189.00K | 190.00K | 190.00K | 160.00K | 100.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 2.34M | -2.71M | 600.00K | -1.06M | 290.00K | |||
| Other non cash items | 787.00K | 19.93M | 670.00K | 720.00K | 46.22M | |||
| OPERATING CASH FLOW | -14.67M | -21.44M | -12.72M | -9.83M | -1.56M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -118.00K | -70.00K | -50.00K | -240.00K | -150.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -118.00K | -70.00K | -50.00K | -240.00K | -150.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -7.00K | -30.00K | -40.00K | -120.00K | -210.00K | |||
| Stock Issued/Repurchased | 4.00M | 0.00 | 38.51M | 35.78M | 6.64M | |||
| FINANCING CASH FLOW | 3.99M | -30.00K | 38.47M | 35.66M | 6.42M | |||
| CHANGE IN CASH | -10.79M | -21.54M | 25.70M | 25.59M | 4.71M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -14.67M | -21.44M | -12.72M | -9.83M | -1.56M | |||
| Capital Expenditure | -118.00K | -70.00K | -50.00K | -240.00K | -150.00K | |||
| FREE CASH FLOW | -14.78M | -21.51M | -12.77M | -10.07M | -1.71M | |||
All data in USD